Objective: To demonstrate sonographic detectable abnormalities of the posterior fossa in fetuses with a crown-rump length of 45–84 mm in high-risk pregnancies. Methods: This was a prospective, observational study including 47 fetuses with known outcome, whose mothers attended our centers for first trimester tests and showed an abnormal first trimester ultrasound scan. In these fetuses, we examined transvaginal acquired three-dimensional volume blocks for abnormalities of the fetal posterior fossa. In these fetuses, the measurements of the cerebellar vermis (VE) and of the anterior membranous area (AMA) were compared with published reference ranges. Results: There were 8 fetuses with a ver-mian length below the 5th centile. In 5 of these fetuses, the AMA was also elongated and in 4 of these fetuses, pathology was confirmed. One case with a normal vermian length and normal AMA had a hypoplastic VE later on in the confirmatory test. Conclusion: Pathology of the posterior fossa can be directly diagnosed by assessing the VE and the AMA at the first trimester scan by examining transvaginal acquired volume blocks.

1.
Hernádi
L
,
Töröcsik
M
.
Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population
.
Prenat Diagn
.
1997
Aug
;
17
(
8
):
753
9
.
[PubMed]
0197-3851
2.
Economides
DL
,
Braithwaite
JM
.
First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population
.
Br J Obstet Gynaecol
.
1998
Jan
;
105
(
1
):
53
7
.
[PubMed]
0306-5456
3.
Whitlow
BJ
,
Chatzipapas
IK
,
Lazanakis
ML
,
Kadir
RA
,
Economides
DL
.
The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population
.
Br J Obstet Gynaecol
.
1999
Sep
;
106
(
9
):
929
36
.
[PubMed]
0306-5456
4.
Souka
AP
,
Nicolaides
KH
.
Diagnosis of fetal abnormalities at the 10-14-week scan
.
Ultrasound Obstet Gynecol
.
1997
Dec
;
10
(
6
):
429
42
.
[PubMed]
0960-7692
5.
Chaoui
R
,
Benoit
B
,
Mitkowska-Wozniak
H
,
Heling
KS
,
Nicolaides
KH
.
Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan
.
Ultrasound Obstet Gynecol
.
2009
Sep
;
34
(
3
):
249
52
.
[PubMed]
0960-7692
6.
Egle
D
,
Strobl
I
,
Weiskopf-Schwendinger
V
,
Grubinger
E
,
Kraxner
F
,
Mutz-Dehbalaie
IS
, et al.
Appearance of the fetal posterior fossa at 11 + 3 to 13 + 6 gestational weeks on transabdominal ultrasound examination
.
Ultrasound Obstet Gynecol
.
2011
Dec
;
38
(
6
):
620
4
.
[PubMed]
0960-7692
7.
Lachmann
R
,
Chaoui
R
,
Moratalla
J
,
Picciarelli
G
,
Nicolaides
KH
.
Posterior brain in fetuses with open spina bifida at 11 to 13 weeks
.
Prenat Diagn
.
2011
Jan
;
31
(
1
):
103
6
.
[PubMed]
0197-3851
8.
Scheier
M
,
Lachmann
R
,
Pětroš
M
,
Nicolaides
KH
.
Three-dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11-13 weeks’ gestation
.
Ultrasound Obstet Gynecol
.
2011
Dec
;
38
(
6
):
625
9
.
[PubMed]
0960-7692
9.
Lachmann
R
,
Sinkovskaya
E
,
Abuhamad
A
.
Posterior brain in fetuses with Dandy-Walker malformation with complete agenesis of the cerebellar vermis at 11-13 weeks: a pilot study
.
Prenat Diagn
.
2012
Aug
;
32
(
8
):
765
9
.
[PubMed]
0197-3851
10.
Bornstein
E
,
Goncalves Rodríguez
JL
,
Álvarez Pavón
EC
,
Quiroga
H
,
Or
D
,
Divon
MY
.
First-trimester sonographic findings associated with a Dandy-Walker malformation and inferior vermian hypoplasia
.
J Ultrasound Med
.
2013
Oct
;
32
(
10
):
1863
8
.
[PubMed]
0278-4297
11.
Volpe
P
,
Contro
E
,
Fanelli
T
,
Muto
B
,
Pilu
G
,
Gentile
M
.
Appearance of fetal posterior fossa at 11-14 weeks in fetuses with Dandy-Walker malformation or chromosomal anomalies
.
Ultrasound Obstet Gynecol
.
2016
Jun
;
47
(
6
):
720
5
.
[PubMed]
0960-7692
12.
Achiron
R
,
Achiron
A
,
Yagel
S
.
First trimester transvaginal sonographic diagnosis of Dandy-Walker malformation
.
J Clin Ultrasound
.
1993
Jan
;
21
(
1
):
62
4
.
[PubMed]
0091-2751
13.
Ichizuka
K
,
Mishina
M
,
Hasegawa
J
,
Matsuoka
R
,
Sekizawa
A
,
Pooh
RK
.
Diagnosis of a case of Dandy-Walker malformation aided by measurement of the brainstem-vermis angle at 14 weeks gestation
.
J Obstet Gynaecol Res
.
2015
May
;
41
(
5
):
790
3
.
[PubMed]
1341-8076
14.
Altmann
R
,
Scharnreitner
I
,
Scheier
T
,
Mayer
R
,
Arzt
W
,
Scheier
M
.
Sonoembryology of the fetal posterior fossa at 11 + 3 to 13 + 6 gestational weeks on three-dimensional transvaginal ultrasound
.
Prenat Diagn
.
2016
Aug
;
36
(
8
):
731
7
.
[PubMed]
0197-3851
15.
Altmann
R
,
Specht
C
,
Scharnreitner
I
,
Schertler
C
,
Mayer
R
,
Arzt
W
, et al.
Reference ranges for transvaginal examined fossa posterior structures in fetuses from 45 to 84 mm crown-rump length
.
Gynecol Obstet Invest
.
2018
;
83
(
4
):
375
80
.
[PubMed]
0378-7346
16.
Malinger
G
,
Lev
D
,
Lerman-Sagie
T
.
The fetal cerebellum. Pitfalls in diagnosis and management
.
Prenat Diagn
.
2009
Apr
;
29
(
4
):
372
80
.
[PubMed]
0197-3851
17.
Bolduc
ME
,
Limperopoulos
C
.
Neurodevelopmental outcomes in children with cerebellar malformations: a systematic review
.
Dev Med Child Neurol
.
2009
Apr
;
51
(
4
):
256
67
.
[PubMed]
0012-1622
18.
Martinez-Ten
P
,
Illescas
T
,
Adiego
B
,
Estevez
M
,
Bermejo
C
,
Wong
AE
, et al.
Non-visualization of choroid plexus of fourth ventricle as first-trimester predictor of posterior fossa anomalies and chromosomal defects
.
Ultrasound Obstet Gynecol
.
2018
Feb
;
51
(
2
):
199
207
.
[PubMed]
0960-7692
19.
Kose
S
,
Altunyurt
S
,
Keskinoglu
P
.
A prospective study on fetal posterior cranial fossa assessment for early detection of open spina bifida at 11-13 weeks
.
Congenit Anom (Kyoto)
.
2018
Jan
;
58
(
1
):
4
9
.
[PubMed]
0914-3505
20.
Robinson
AJ
.
Inferior vermian hypoplasia—preconception, misconception
.
Ultrasound Obstet Gynecol
.
2014
Feb
;
43
(
2
):
123
36
.
[PubMed]
0960-7692
21.
Cho
KH
,
Rodríguez-Vázquez
JF
,
Kim
JH
,
Abe
H
,
Murakami
G
,
Cho
BH
.
Early fetal development of the human cerebellum
.
Surg Radiol Anat
.
2011
Aug
;
33
(
6
):
523
30
.
[PubMed]
0930-1038
22.
Hochstetter
F
.
Beiträge zur entwicklungsgeschichte des menschlichen gehirns
.
Wien, Leipzig
:
Franz Deuticke
;
1929
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.